Skip to content

Expandability of Aging Adipose Tissue

Aging Subcutaneous Adipose Tissue Response to Overfeeding

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02456870
Acronym
EAT
Enrollment
20
Registered
2015-05-29
Start date
2015-06-30
Completion date
2018-12-31
Last updated
2019-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Obesity

Keywords

Adipose tissue, Overfeeding

Brief summary

The purpose of this pilot study is to determine whether adipose tissue loses some of its ability to expand in response to overfeeding in older compared to younger men. The investigators hypothesize that the adipose tissue response to overfeeding may be weakened in older when compared to younger men, thereby leading to worsened ectopic storage depots for older men.

Detailed description

This pilot study will begin to address whether adipose tissue biology changes with advancing age. Specifically, we will test whether adipose tissue loses some of its ability to expand in response to overfeeding in older compared to younger men. To test this possibility the Investigators will recruit overweight and mildly obese older (age 55-75y) and younger (age 25-40y) men and collect adipose tissue biopsies before and after 7 days of overfeeding. The investigators will test how well the cells in adipose tissue expand in response to overfeeding and whether this differs between younger and older men.

Interventions

Consumption of 40% excess calories for 7 consecutive days

Sponsors

Colorado State University
CollaboratorOTHER
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Men * Aged 25-40y OR 55-75y * BMI 28-35 kg/m2 * Weight stable (±2kg over past 3 mo) * Sedentary to moderately active (\<3 d/wk of exercise lasting \>20min) * Non-smokers (never used or quit \>7yrs prior)

Exclusion criteria

* Women * Currently using hormones, glucose or lipid lowering medication * Engaged in exercise or diet program * Currently gaining or losing weight or using weight loss drugs * Diabetes mellitus (diagnosis, treatment, FBG ≥126 mg/dL) * Uncontrolled metabolic disorders (e.g., thyroid)

Design outcomes

Primary

MeasureTime frameDescription
Change in adipose-derived stem cell (ASC) differentiation (Delta%oil red O+)1 wk of overfeedingage-related difference in the ASC differentiation response to overfeeding

Secondary

MeasureTime frameDescription
Change in ASC proliferation (Delta rate of cell growth)1 wk of overfeedingage-related difference in the ASC proliferative response to overfeeding
Change in expression of C/EBPalpha, C/EBPbeta, PPARgamma2, SREBP1c, SREBf1a, and Wnt10b (fold-changes in mRNA expression)1 wk overfeedingage-related difference in the pro-adipogenic response to overfeeding
Change in intramyocellular (IMCL) di-saturated diacylglycerol (DAG) localization (Delta %membrane:cytosol)1 week overfeedingage-related difference in the IMCL DAG response to overfeeding

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026